Mechanistically, MYCN activates Aurora-A on the chromatin of neuroblastoma cells, where it phosphorylates S10 of histone H3 during the DNA-replicating S-phase of the cell cycle [196]. The gene discussed is MYCN; the disease is neuroblastoma.